Invokana Injury Lawyer In Fort Lauderdale
Invokana (canagliflozin) is a prescription medication to lower blood sugar in adults with type 2 diabetes. It is an SGLT2 inhibitor, or a class of medication doctors use to treat symptoms of type 2 diabetes. Invokana, a Johnson & Johnson drug, has been the topic of legal debate in recent years. After reports of adverse reactions, symptoms, and side effects, many patients taking Invokana filed lawsuits against the manufacturer. The greatest risk Invokana poses is ketoacidosis, or a buildup of acid in your blood due to high blood sugar. Ketoacidosis can be fatal. Our Fort Lauderdale personal injury attorneys want to help anyone who has experienced adverse effects after taking Invokana.
Dangers Relating to Invokana
In 2015, the Food and Drug Administration (FDA) issued a warning against SGLT2 inhibitors for patients with diabetes. This warning focused on the risk of developing ketoacidosis after taking medications that acted as SGLT2 inhibitors. The FDA warns of a variety of adverse outcomes and side effects that patients have reported after taking these medications. Despite these drugs having FDA’s seal of approval, the Administration warns patients to watch carefully for signs of ketoacidosis while taking these medications, including Invokana. Signs of major health issues relating to Invokana include:
- Pain in the abdomen
- Nausea and vomiting
- Frequent urination
- Persistent thirst
- Dry mouth and skin
The FDA instructs anyone with these side effects taking an SGLT2 inhibitor to seek medical attention right away for possible ketoacidosis. Aside from ketoacidosis, Invokana may also cause kidney problems or failure, urinary tract infections, and heart attacks in patients. The FDA warning about these drugs requires manufacturers to include “black box” warnings, or those that call attention to possible life-threatening risks of taking the medication. The FDA issued this statement after two studies found the risks of leg and foot amputations were twice as high for those taking SGLT2 inhibitors. Patients who have already suffered harms from taking Invokana may be eligible for compensation.
Invokana Lawsuits and Settlements
Johnson & Johnson released Invokana about three years before the FDA’s warning regarding SGLT2 inhibitors. There is an ongoing argument that the drug manufacturing company should have included a black box label from the beginning, due to the high risk of ketoacidosis. There are currently dozens of Invokana lawsuits pending in courts around America. They are awaiting trial in a multidistrict litigation in New Jersey. No parties have announced settlements as of yet, but there is reason to believe the courts will rule in plaintiffs’ favor if it finds that Johnson & Johnson reasonably should have known of the risks of taking the drug.
Invokana is a dangerous and possibly deadly drug. We believe Johnson & Johnson should take responsibility for the harms this blood sugar medication has caused to unsuspecting patients. If you believe you have grounds to join the current lawsuit regarding Invokana, contact our team of experienced attorneys; we can give you the most up-to-date information about Invokana lawsuits in Florida and around the country. Plaintiffs involved in defective drug claims have won significant settlements and judgment awards in the past.
If you or someone you love have experienced the effects of this dangerous drug, Jason and Debi Chalik want to hear your story. Call the Law Offices of Chalik & Chalik for a free, no obligation consultation today.